⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
PTIX News
Form 8-K
sec.gov
PTIX
PTIXW
Form 8-K
sec.gov
PTIXW
PTIX
Delisting of Securities from The Nasdaq Stock Market
globenewswire.com
ADNT
SOND
ISRL
IRBT
KAVL
LAZR
ZYXI
PTIX
Results from Phase 1 Multiple-Dose Study of PT00114
accessnewswire.com
PTIX
Protagenic Therapeutics Announces Receipt of Nasdaq Non-Compliance Notice
accessnewswire.com
PTIX
Protagenic Therapeutics Announces Completion of Enrollment and Dosing in Phase 1 MAD Study
accessnewswire.com
PTIX
Protagenic Therapeutics Provides Update on Form 10-Q Filing Timeline and Nasdaq Compliance
accessnewswire.com
PTIX
PTIX
Protagenic Therapeutics Advances PT00114 into Multiple-Dose Phase 1 Trial; Positioning for Phase 2 in Stress & Mood Disorders
accessnewswire.com
PTIX
PTIX